Imatinib Mesylate
Average across 17 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Apotex Corp. | unknown | 10 | SUPPLYING |
| SUN PHARMACEUTICAL INDUSTRIES, INC. | unknown | 6 | SUPPLYING |
| BluePoint Laboratories | unknown | 4 | SUPPLYING |
| Aurobindo Pharma Limited | unknown | 3 | SUPPLYING |
| Major Pharmaceuticals | unknown | 2 | SUPPLYING |
| Quallent Pharmaceuticals Health LLC | unknown | 2 | SUPPLYING |
| Camber Pharmaceuticals, Inc. | unknown | 2 | SUPPLYING |
| Teva Pharmaceuticals USA, Inc. | unknown | 2 | SUPPLYING |
| Armas Pharmaceuticals Inc. | unknown | 2 | SUPPLYING |
| CivicaScript LLC | unknown | 2 | SUPPLYING |
| Chartwell RX, LLC. | unknown | 2 | SUPPLYING |
| Ascend Laboratories, LLC | unknown | 2 | SUPPLYING |
| American Health Packaging | unknown | 1 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
CGMP Deviations — Recalling firm: Shilpa Medicare Limited — Nationwide in the U.S.
CGMP Deviations — Recalling firm: Shilpa Medicare Limited — Nationwide in the U.S.
Pill